 Home > Medical News > Latest Medical News > Suzhou Ruibo Biotechnology Co., Ltd. uses ArisGlobal's LifeSphere® MultiVigilance solution to improve its clinical trial data management

Suzhou Ruibo Biotechnology Co., Ltd. uses ArisGlobal's LifeSphere® MultiVigilance solution to improve its clinical trial data management

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

french number system

pantoprazole drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

MIAMI, November 1, 2021/PRNewswire/ - ArisGlobal, a leading provider of life science software that automates core drug R&D with the end-to-end drug development technology platform LifeSphere®, today announced its commitment to the development of RNA interference (RNAi) technology.
The innovative research and development company (Ribo Bio) of nucleic acid drugs and related products formally established a cooperative relationship
.

Ruibo Bio will use the Chinese and English versions of ArisGlobal's LifeSphere Multivigilance to manage its drug safety data and meet the regulatory requirements for its products to enter the clinical trial phase

"Drug clinical trials will generate a large amount of safety data.
To bring drugs to the market safely, careful and purposeful insights are essential
.

Ruibo Biosciences has a large number of independent research and development pipelines for small nucleic acid drug therapy, LifeSphere Multivigilance A data model can be provided to connect isolated security data sets in the global market and combine them into a valuable data architecture

Multivigilance is a project in the LifeSphere security product line.
It is an end-to-end automation system designed to help pharmacovigilance teams save time and effort, ensure future-oriented compliance, and align global teams
.

The platform uses artificial intelligence to simplify the existing workflow of the pharmacovigilance team and ensure 100% compliance with current and future regulatory compliance requirements

"As Ruibo Biotechnology continues to bring innovative drugs into clinical trials globally, we need to choose a pharmacovigilance system with stable performance, strong data management capabilities, and innovative spirit
.

We are very confident in ArisGlobal's products.

Prior to this, ArisGlobal held important discussions on security, automation and artificial intelligence applications and data at its iconic conference Breakthrough2021, and released a report on the state of life science research and development technology in 2021

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.